Ashfield Capital Partners’s 9 Meters Biopharma, Inc. Common Stock NMTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $7K | Hold |
1,668
| – | – | ﹤0.01% | 228 |
|
|
2022
Q2 | $9K | Hold |
1,668
| – | – | ﹤0.01% | 229 |
|
|
2022
Q1 | $20K | Hold |
1,668
| – | – | ﹤0.01% | 235 |
|
|
2021
Q4 | $33K | Hold |
1,668
| – | – | ﹤0.01% | 235 |
|
|
2021
Q3 | $43K | Hold |
1,668
| – | – | ﹤0.01% | 231 |
|
|
2021
Q2 | $37K | Hold |
1,668
| – | – | ﹤0.01% | 232 |
|
|
2021
Q1 | $39K | Hold |
1,668
| – | – | ﹤0.01% | 231 |
|
|
2020
Q4 | $29K | Hold |
1,668
| – | – | ﹤0.01% | 233 |
|
|
2020
Q3 | $27K | Hold |
1,668
| – | – | ﹤0.01% | 220 |
|
|
2020
Q2 | $19K | Hold |
1,668
| – | – | ﹤0.01% | 215 |
|
|
2020
Q1 | $17K | Buy |
+1,668
| New | +$17K | ﹤0.01% | 214 |
|